Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Jakšić, Hrvoje
DOB: 23-JUL-1986 (Age: 39)
Gender: male
Address:
Kirchenallee 21
94557 Niederalteich (Germany)
ID: 5550-400599-6
Report
Date: 10-SEP-2024
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
ASKLEPIOS Klinik Schaufling
Hausstein 2
94571 Schaufling (Germany)
Specimen
Collected: 09-SEP-2024

Chemistry

Test 09 Sep 2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.4 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 113.2 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.8 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 1.1 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 138.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 101.3 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.0 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 221.7 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 160.7 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 139.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.4 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 1.2 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c and recent fasting glucose, indicating suboptimal glycemic control and likely diabetes. Lipid profile has worsened over time, with high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function and electrolytes are within normal limits, and no microalbuminuria is present. Recommend intensifying diabetes and lipid management and regular follow-up.